Myriad Genetics Inc (NAS:MYGN)
$ 26.835 0.445 (1.69%) Market Cap: 2.44 Bil Enterprise Value: 2.44 Bil PE Ratio: 0 PB Ratio: 3.29 GF Score: 78/100

Myriad Genetics Inc at Cowen Health Care Conference Transcript

Mar 12, 2019 / 01:20PM GMT
Release Date Price: $31.89 (+6.41%)
Doug Schenkel
Cowen and Company - Analyst

All right, good morning, everyone. I am Doug Schenkel from the healthcare team here at Cowen. It's my pleasure to welcome you to the presentation by Myriad Genetics. From the Company we have Mark Capone, the Company's President and Chief Executive Officer. We also have Scott Gleason, who runs IR, with us.

The format for this session will be I think a full presentation. If we happen to have some time at the end maybe we can do a question or two. But I know there's lots to talk about. So assuming that doesn't happen, we have a breakout session set up next door. I will double check, but I believe that is in Salon D, which is right there. So Mark and Scott, thanks for being here. Let me hand it over to Mark.

Mark Capone
Myriad Genetics, Inc. - President & CEO

So good morning and thank you. Doug and Cowen always do an outstanding job. We are delighted to be here this morning and talk to you about some of the exciting opportunities we have at Myriad Genetics. Just as a reminder, the presentation may contain

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot